FULC
NASDAQStockFulcrum Therapeutics, Inc.
$7.54-0.10 (-1.25%)
52-Week Range
$2.51
$14.60
Key Stats
Market Cap
407.7M
P/E Ratio
—
Dividend Yield
—
Beta
3.29
Volume
347.0K
Avg Volume
1.3M
Performance
1M
-28.22%
3M
-40.94%
6M
+4.52%
YTD
-30.13%
1Y
+144.55%
3Y
+107.34%
5Y
-37.15%
Price Chart
ETF Exposure
FULC is held by 64 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
PreviousPage 2 of 2
About FULC ETF Exposure
Fulcrum Therapeutics, Inc. (FULC) is held by 64 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 407.7M, FULC is a widely held institutional stock. The stock currently trades at $7.54. Investors can gain exposure to FULC through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold FULC, sorted by portfolio weight.